TTC and USciences Sponsors "The State of Clinical Development Costs" Conference in Philadelphia
On January 11-12, 2011 TTC, llc, provider of industry-wide cost benchmarking tools, and the University of the Sciences in Philadelphia (USciences) sponsored the “The State of Clinical Development Costs" conference. Drawing 80 decision makers and specialists from a host of pharmaceutical, biotechnology and medical device companies, and CROs, the 2-day event included two keynote addresses, one by David Fairbrother, Director of Clinical Budgeting at Forest Laboratories, and Hani Zaki, Senior Vice President of PRA International, who spoke on “Future Challenges of Clinical Development; a View from the CRO."
The conference highlighted evidenced based decision-making and research findings. Proceeds from the conference are to be devoted to pursue evidence based research issues that arose during the session. TTC “State of Clinical Development” conference panels addressed a range of topics;“Effective Budgeting and Management of CRO Costs,” “Standard of Care Costs in Clinical Trials, and “Compliance and Fair Market,” “Clinical Trial Costs in Emerging Geographies,” and “Standard of Care Costs in Clinical Trials.”
Additional presentations were given by Dr. Patricia R. Audet on "Productivity and Costs in Today's HealthCare Arena," and by Dr. Laurence Poli of TTC on how CROs and sponsor companies can work together more efficiently.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
